TNJIF yields 5.08% · PFE yields 6.13%● Live data
📍 TNJIF pulled ahead of the other in Year 1
Combined, TNJIF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TNJIF + PFE for your $10,000?
Tianjin Capital Environmental Protection Group Company Limited, together with its subsidiaries, engages in the sewage treatment and construction of the sewage treatment plants in the People's Republic of China. It operates through Sewage Water Processing and Water Plant Facilities Construction; Recycled Water and Pipeline Connection; Heating and Cooling Supply and Related Facilities Construction; Tap Water and Water Plant Facilities Construction; Sale of Environmental Protection Equipment; and All Other segments. The company offers municipal sewage treatment, and water supply and recycling services, as well as sludge treatment, photovoltaic power generation, transformation of achievements in technology research, etc.; and involved in hazardous wastes business. It also provides toll collection services; environment governance, technical consulting services, etc.; technical consulting for water recycling business; energy saving and research, consulting and transfer, and property management services; and industrial solid waste incineration and disposal, and general waste recycling services, as well as invests in construction projects; and manufactures and sells new building materials. The company was founded in 1993 and is based in Tianjin, the People's Republic of China. Tianjin Capital Environmental Protection Group Company Limited is a subsidiary of Tianjin Municipal Investment Company Limited.
Full TNJIF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.